McCormick Q1: adj. EPS $0.66 (+10%); net sales +16.7% on Mexico acquisition; FY outlook reaffirmed

MCCORMICK & CO INC

2026-Q1 EPS reported $3.77 revenue$1,873,900,000

Net sales +16.7% to $1.87B; organic sales +1.2%; McCormick de Mexico acquisition contributed 12.4%.
Adj. EPS $0.66 vs $0.60 (+10%); reported EPS $3.77 includes non-cash $3.22 gain from Mexico acquisition.
Adj. operating income $268M (+18.8%); margin expanded 30bps to 14.3%.
FY2026 outlook reaffirmed: net sales growth 13-17% reported, adj. EPS $3.05-$3.13, adj. op income growth 16-20%.
Consumer segment sales +24.5% (acquisition-driven); Flavor Solutions +6.2%.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000063754-26-000189
form_type: 8-K
ticker: MKC
cik: 0000063754
company_name: MCCORMICK & CO INC
filed_at: 2026-03-31T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.470091+00:00
generated_at: 2026-05-15T08:17:51.330890+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: positive
materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000063754-26-000189
json_url: https://secwatch.observer/filing/0000063754-26-000189.json
markdown_url: https://secwatch.observer/filing/0000063754-26-000189.md
text_url: https://secwatch.observer/filing/0000063754-26-000189.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/63754/000006375426000189/0000063754-26-000189-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/63754/000006375426000189/mkc-20260331.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0000063754-26-000189

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.